Association Between Obesity-Mediated Atrial Fibrillation and Therapy With Sodium Channel Blocker Antiarrhythmic Drugs.
Ornelas-Loredo A, Kany S, Abraham V, Alzahrani Z, Darbar FA, Sridhar A, Ahmed M, Alamar I, Menon A, Zhang M, Chen Y, Hong L, Konda S, Darbar D.
Ornelas-Loredo A, et al. Among authors: ahmed m.
JAMA Cardiol. 2020 Jan 1;5(1):57-64. doi: 10.1001/jamacardio.2019.4513.
JAMA Cardiol. 2020.
PMID: 31774463
Free PMC article.